The global transplantation market size is expected to reach USD 32.94 Billion in 2030 and register a revenue CAGR of 11.5% during the forecast period. Increases cases of organ failure, is resulting in rising demand for tissue transplantation and organ transplantation products, which is a major factor driving global transplantation market revenue growth.
One of the most significant advancements in modern medicine is organ transplantation. It is a medical technique in which an organ or tissue is surgically removed from one person (the organ donor) and implanted into another person (the organ recipient). Organ transplants cannot be performed without consent of the patient or without consent of the patient family and if done, it is considered illegal or a crime.
Major factors driving the transplantation market revenue growth are increased consumption of alcohol and other harmful substances, as well as an unhealthy lifestyle, resulting in gradual damage of organs. Cardiovascular disease, diabetes, cancer, renal illness, and Alzheimer’s disease, among others, affect a huge section of the world’s population and can lead to organ and tissue failure.
Request a Sample@ https://qyresearchmedical.com/sample/119094
Human organs such as kidney, lung, liver, pancreas, cornea, and skin can be transplanted. Transplants aid in the restoration of a healthy body and help the patient live a healthy lifestyle. Technological advancements help in improving the success rate of transplants. Furthermore, advanced software and systems make tissue and organ preservation more convenient.
Growing adoption of tissue and organ transplantation due to continuous development of more advanced surgical technologies, improved healthcare infrastructure, and increased awareness about organ donation. Growing number of tissue banks, as well as development of technologically advanced devices are driving revenue growth of the market. In the transplantation industry, evolvement of innovative 3D printing technology designed to create an organ/tissue that is similar to the one within the body is expected to drive revenue growth of the market. In addition, programs and campaigns by government of various countries across the world, such as donation campaigns to raise awareness about organ donation, is resulting in increasing number of organ donors.
However, there is a significant gap between demand for organ transplantation and availability of human organs and tissue, which is mostly due to lack of education and knowledge about organ donation, as well as religious myths,that could limit market revenue growth.
Driver: Increasing incidence of organ failure
Rising demand for organ transplantation across the globe since the past decade due to increased prevalence of vital organ failure, rising success rate of transplantation, and greater improvement in post-transplant outcomes. Rising incidence of organ failure due to increased consumption of alcohol and other harmful substances, as well as unhealthy diet which is leading to various chronic diseases causing failure of vital organs such as lungs, kidney, liver, and many more. Patients need organ transplantations to survive, which is driving transplantation market revenue growth. Also, technological advancements in transplantation methods is driving market revenue growth.
Restraint: Lack of Registered Donors and Difficulties in Obtaining Organs
When compared to the number of patients that require transplantation, the number of organ donors is very less. Life span of people has increased due to breakthroughs in medical science and surgical procedures. As a result of these remarkable advances in medical technology, there are fewer organ donors available for transplantation, due to growing survival rate. However, there are a large number of patients on the waiting list for organ transplants. According to a study, every ten minutes, an individual is registered to the waiting list, and 20 people die every day while waiting for an organ.
People tend to be apprehensive to register as organ donors due to myths or no willingness. In addition, there are many misconceptions such as that only the heart, liver, and kidneys can be donated, and that if the healthcare professionals learn that the patient is an organ donor, they might not focus or give their full attention to save that patient’s life. Other religious beliefs, which makes individuals hesitant about becoming registered donors. Moreover, continuous advancements in medical treatments is resulting in difficulty in procuring organs, as people are living for longer life spans in parallel to development of more advanced treatments and therapies. As per a study, only three people out of 1,000 die in a manner that enables organ donation.
Based on product, the global transplantation market is segmented into tissue products, immunosuppressive drugs, and preservation solutions.
Tissue product segment accounted for largest revenue share in 2021 because of increasing need for tissue and organ transplantation. Increased prevalence of diseases including diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer’s disease has put a large population at risk of irreversible tissue damage, requiring a greater need for tissue transplantation, which is driving revenue growth of the segment.
Immunosuppressive drugs segment revenue is expected to register a steady growth rate during the forecast period. Immunosuppressive drugs are used commonly to prevent tissue or organ rejection after transplantation. It is highly beneficial for the patients in the post-transplant period, which is expected to result in high demand for immunosuppressive drugs, thereby driving revenue growth of the segment during the forecast period.
Application Type Insights:
Based on wound type, the global transplantation market is segmented into organ transplant and tissue transplant.
Organ transplant segment accounted for largest revenue share in 2021. Rising demand for organ transplantation across the world, due to increasing number of organ failure cases related to heavy alcohol use and an unhealthy lifestyle. In addition, the success rate is increasing, and the post-transplant prognosis is improving as a result of continuous technological developments by major players and healthcare professionals, which is driving revenue growth of the segment.
Tissue transplant segment revenue is expected to register a steady growth rate during the forecast period. There is high demand for transplants of cornea, bones, skin, nerves, tendons, veins, and heart valves, especially for burnt and accident victims.
Based on end-use, the global transplantation market is segmented into hospitals, transplant centers and others.
Hospital segment accounted for largest revenue share in 2021 as a result of rising number of medical procedures and operations performed in hospitals. Most hospitals have easy and more accessibility to well-defined organ databases, which could be used to verify the supply of requested organs, allowing for quicker medical action which is driving revenue growth of the segment.
Transplant centers segment is expected to register a steady revenue growth rate during the forecast period, due to growing need for advanced healthcare centers as demand for transplantation procedures is inclining, and transplant centers being an ideal option for older adults as it provides personalized care and prevents frequent trips to the hospitals. In addition, treatment in transplant centers also limits risks related to hospital-acquired infections.
Based on regional analysis, transplantation market in North America accounted for largest revenue share in 2021. Continuous development of innovative transplantation products for treatment, well-developed healthcare system and increasing expenditure on personal health by the population are factors driving revenue growth of the market in this region. In addition, strong presence of various large-scale biotechnology and medical device companies is expected to drive revenue growth of the North America market. Moreover, presence of supportive government policies in Canada and the US is supporting revenue growth of the market in this region.
Market in Asia Pacific is expected to register faster revenue growth rate during the forecast period. Rising prevalence of various chronic diseases and increasing incidence of road accidents are causing permanent damage to the organs resulting in replacement of damaged organs with healthy organs in order to save patient’s life, which are major factors driving revenue growth of the market in this region. In addition, continuous advancements in transplantation technology by major players in countries in this region is driving Asia Pacific transplantation market revenue growth.
Market in Europe is expected to register a steady high revenue growth rate during the forecast period. Increasing consumption of drugs and alcohol are causing organ damage and this coupled with strong presence of major market players and availability of skilled doctors are driving revenue growth of the market in the region.
Competitive landscape of the global transplantation market is consolidated with few key players operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolio and gain a robust footing in the global market. Major players in the market include Veloxis Pharmaceuticals, Inc., Abbott, Becton, Dickinson, and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., CareDx, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc, Illumina, Inc., and QIAGEN.
Initiatives taken by market players are driving growth of the market, for instance:
On February 2022, Hansa Biopharma AB, a Sweden-based company, announced that it has got authorization from French Haute Autorité de Santé (HAS) for Idefirix. The company will use Idefirix to desensitize highly sensitized patients undergoing kidney transplants.
On September 2021, Kidney Transplant Collaborative (KTC) launched a national nonprofit organization based in Washington, DC. KTC is a non-profit organization devoted to increasing kidney transplants while reducing financial barriers and other issues that recipients and donors require throughout the transplant process.
Segments Covered in the Report
This report offers historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the sub-segments from 2022 to 2030. For this study, Reports and Data have segmented the global transplantation market based on product, application, end-use, and region:
Transplantation Market Report Scope
Segments covered By Product Outlook, Wound Type Outlook, End-use Outlook, Regional Outlook
By Product Outlook
By Wound Type Outlook
By End-use Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119094/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: